535 related articles for article (PubMed ID: 19727388)
1. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
[TBL] [Abstract][Full Text] [Related]
3. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
Wozniak KL; Young ML; Wormley FL
Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-17A on resolution of pulmonary C. neoformans infection.
Wozniak KL; Hardison SE; Kolls JK; Wormley FL
PLoS One; 2011 Feb; 6(2):e17204. PubMed ID: 21359196
[TBL] [Abstract][Full Text] [Related]
6. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.
Wozniak KL; Hole CR; Yano J; Fidel PL; Wormley FL
Microbiology (Reading); 2014 Jul; 160(Pt 7):1440-1452. PubMed ID: 24760968
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
Hardison SE; Wozniak KL; Kolls JK; Wormley FL
Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
[TBL] [Abstract][Full Text] [Related]
8. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
10. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.
Young M; Macias S; Thomas D; Wormley FL
Proteomics; 2009 May; 9(9):2578-88. PubMed ID: 19343717
[TBL] [Abstract][Full Text] [Related]
11. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.
Wozniak KL; Kolls JK; Wormley FL
BMC Immunol; 2012 Dec; 13():65. PubMed ID: 23216912
[TBL] [Abstract][Full Text] [Related]
12. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.
Wormley FL; Perfect JR; Steele C; Cox GM
Infect Immun; 2007 Mar; 75(3):1453-62. PubMed ID: 17210668
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
[TBL] [Abstract][Full Text] [Related]
14. Induction of Broad-Spectrum Protective Immunity against Disparate
Van Dyke MCC; Chaturvedi AK; Hardison SE; Leopold Wager CM; Castro-Lopez N; Hole CR; Wozniak KL; Wormley FL
Front Immunol; 2017; 8():1359. PubMed ID: 29163469
[TBL] [Abstract][Full Text] [Related]
15. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
Jain AV; Zhang Y; Fields WB; McNamara DA; Choe MY; Chen GH; Erb-Downward J; Osterholzer JJ; Toews GB; Huffnagle GB; Olszewski MA
Infect Immun; 2009 Dec; 77(12):5389-99. PubMed ID: 19752036
[TBL] [Abstract][Full Text] [Related]
16. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
[TBL] [Abstract][Full Text] [Related]
17. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
mBio; 2016 May; 7(3):. PubMed ID: 27165801
[TBL] [Abstract][Full Text] [Related]
18. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
Olszewski MA; Huffnagle GB; McDonald RA; Lindell DM; Moore BB; Cook DN; Toews GB
J Immunol; 2000 Dec; 165(11):6429-36. PubMed ID: 11086082
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.
Murdock BJ; Huffnagle GB; Olszewski MA; Osterholzer JJ
Infect Immun; 2014 Mar; 82(3):937-48. PubMed ID: 24324191
[TBL] [Abstract][Full Text] [Related]
20. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.
Guillot L; Carroll SF; Homer R; Qureshi ST
Infect Immun; 2008 Oct; 76(10):4745-56. PubMed ID: 18678664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
